- Home
- AIRE vs EDSA Comparison
AIRE vs EDSA Comparison
Compare AIRE & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRE
- EDSA
- Stock Information
- Founded
- AIRE 2021
- EDSA 2015
- Country
- AIRE United States
- EDSA Canada
- Employees
- AIRE N/A
- EDSA 16
- Industry
- AIRE
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- AIRE
- EDSA Health Care
- Exchange
- AIRE Nasdaq
- EDSA Nasdaq
- Market Cap
- AIRE 13.9M
- EDSA 14.7M
- IPO Year
- AIRE N/A
- EDSA N/A
- Fundamental
- Price
- AIRE $0.21
- EDSA $2.39
- Analyst Decision
- AIRE Strong Buy
- EDSA Strong Buy
- Analyst Count
- AIRE 1
- EDSA 2
- Target Price
- AIRE $1.25
- EDSA $13.00
- AVG Volume (30 Days)
- AIRE 7.7M
- EDSA 30.7K
- Earning Date
- AIRE 08-21-2025
- EDSA 08-08-2025
- Dividend Yield
- AIRE N/A
- EDSA N/A
- EPS Growth
- AIRE N/A
- EDSA N/A
- EPS
- AIRE N/A
- EDSA N/A
- Revenue
- AIRE $1,853,629.00
- EDSA N/A
- Revenue This Year
- AIRE $369.52
- EDSA N/A
- Revenue Next Year
- AIRE $68.67
- EDSA N/A
- P/E Ratio
- AIRE N/A
- EDSA N/A
- Revenue Growth
- AIRE 1925.60
- EDSA N/A
- 52 Week Low
- AIRE $0.14
- EDSA $1.55
- 52 Week High
- AIRE $4.49
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- AIRE 21.02
- EDSA 73.15
- Support Level
- AIRE $0.14
- EDSA $1.89
- Resistance Level
- AIRE $0.27
- EDSA $2.23
- Average True Range (ATR)
- AIRE 0.03
- EDSA 0.11
- MACD
- AIRE -0.00
- EDSA 0.04
- Stochastic Oscillator
- AIRE 16.78
- EDSA 81.54
About AIRE reAlpha Tech Corp.
ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.